Shopping Cart

Research Shows Imagion Nanoparticles Enable Low-field MRI

Research Shows Imagion Nanoparticles Enable Low-field MRI

Imagion Biosystems Limited is pleased to share news of research published by collaborators from the University of Sydney demonstrating that Imagion’s iron oxide nanoparticles enable low-field magnetic resonance imaging, which could provide a significant advancement in medical imaging by reducing the cost and improving the accessibility of MRI. This research reinforces the significance of the clinical and commercial opportunity for Imagion’s nanoparticles.

Read the announcement.

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.